Drug intelligence / Profile preview

L-lactate

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous, Topical
01

Overview

L-lactate is the physiological (S)-enantiomer of lactate, a key metabolic intermediate produced during glycolysis. In clinical practice, it is most commonly administered as sodium lactate via intravenous infusion for fluid resuscitation and the treatment of metabolic acidosis, often as a component of crystalloid solutions like Lactated Ringer's or Hartmann's solution. Upon administration, L-lactate is primarily metabolized in the liver to bicarbonate, thereby exerting a systemic alkalizing effect. Beyond its role as a buffering agent and fuel source, L-lactate functions as a signaling molecule by acting as an agonist for the hydroxycarboxylic acid receptor 1 (HCAR1/GPR81). Recent research has also identified L-lactate as a substrate for lysine lactylation (Kla), a post-translational modification that regulates protein stability and gene expression. In the context of pancreatic ductal adenocarcinoma (PDAC), lactate-driven lactylation of the RNA methyltransferase NSUN2 has been shown to promote perineural invasion and disease progression by stabilizing pro-invasive transcripts.

Brand names
Sodium Lactate
Other names
(S)-2-hydroxypropanoateL-lactic acidSarcolactic acid(S)-lactate
02

Targets

MCT4 (Monocarboxylate transporter 4)HCAR1 (Hydroxycarboxylic acid receptor 1)SLC16A1 (Mitochondrial Pyruvate Carrier)

Beyond the preview

Go deeper on L-lactate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-lactate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call